Aerovate Therapeutics
AVTE
#8977
Rank
NZ$99.15 M
Marketcap
$3.43
Share price
1.67%
Change (1 day)
-84.49%
Change (1 year)

Aerovate Therapeutics (AVTE) - Net assets

Net assets on the balance sheet as of June 2024 : NZ$0.15 B

According to Aerovate Therapeutics's latest financial reports the company has NZ$0.15 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Aerovate Therapeutics - Net assets on balance sheet (from 2020 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$NZ$0.19 B-20.71%
2021-12-31$NZ$0.25 B-1456.92%
2020-12-31$-NZ$18.56 M243.56%
2019-12-31$-NZ$5.41 M